Listed by the USPTO as WRUBLESKI, MATTHEW JAMES
Tech Center 3700 • Art Units: 3781 3783
This examiner grants 59% of resolved cases
WRUBLESKI, MATTHEW JAMES works in Tech Center 3700 and Art Unit 3781. Among 118 resolved cases, the allowance rate is 59.3%, the interview lift is 60.1%, and the median time to allowance is 1108 days. The interview measure is the dominant feature of this record, indicating that examiner discussions may be particularly valuable when carefully prepared. The allowance result still calls for written responses that preserve a complete prosecution position.
The leading companies are PureWick Corporation, The Procter & Gamble Company, and Smith & Nephew plc. The leading firms are OLIFF PLC, AMSTER, ROTHSTEIN & EBENSTEIN LLP, and Dinsmore & Shohl LLP. The applicant mix centers on healthcare and consumer products. Practitioners may want to use interviews to explain functional relationships and propose focused amendments, while recognizing the limited case volume.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18976779 | ABSORBENT ARTICLE | Non-Final OA | The Procter & Gamble Company |
| 17962571 | FEMININE HYGIENE PAD WITH FOAM ABSORBENT AND RESERVOIR SPACER LAYER | Final Rejection | The Procter & Gamble Company |
| 18696653 | WOUND DRESSING APPARATUSES AND METHODS FOR NITRIC OXIDE DELIVERY | Non-Final OA | T.J.Smith and Nephew,Limited |
| 18568646 | Drainage System Including Actuation Device For Providing A Negative Pressure For Draining And Collecting Bodily Fluids | Non-Final OA | Becton Dickinson and Company |
| 18566362 | DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18880957 | SHUNT FOR FIBROUS ENCAPSULATION IN GLAUCOMA PATIENTS | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18570167 | BLOOD PURIFICATION APPARATUS | Final Rejection | NIKKISO CO., LTD. |
| 19049501 | FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE OF A PROTRUSION OR AT LEAST ONE EXPANDABLE MATERIAL | Non-Final OA | PUREWICK CORPORATION |
| 19048004 | FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE INFLATION DEVICE AND METHODS AND SYSTEMS OF USING THE SAME | Non-Final OA | PUREWICK CORPORATION |
| 19038774 | FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE LENGTH ADJUSTING FEATURE | Non-Final OA | PUREWICK CORPORATION |
| 18549387 | FLUID COLLECTION DEVICE | Non-Final OA | PUREWICK CORPORATION |
| 18150360 | FLUID COLLECTION DEVICES INCLUDING A DRY ADHESIVE REGION, AND RELATED SYSTEMS AND METHODS | Non-Final OA | PUREWICK CORPORATION |
| 18293491 | CLAMPING ELEMENT FOR A PUMP DEVICE | Non-Final OA | Fresenius Medical Care Deutschland GmbH |
| 18706470 | NEGATIVE PRESSURE WOUND THERAPY DRESSING WITH ISOLATED SUPER ABSORBENT | Non-Final OA | KCI Manufacturing Unlimited Company |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy59.3% of resolved applications examined by Matthew James Wrubleski were allowed (118 resolved cases), compared with 50.6% across Art Unit 3781 over the last five years.
This examiner's interview lift is +60.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Matthew James Wrubleski took 1,108 days on average from filing to allowance.
Matthew James Wrubleski examines applications in Art Unit 3781 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
